CMS Initiatives Regarding Pain-Management Issues
In 2018, CMS adopted a three-pronged approach to the public-health emergency posed by opioid use.
Comparison of Chronic Pain and High-Impact Chronic Pain
The 2016 National Health Interview Survey found that high-impact chronic pain and chronic pain that does not limit major life activities were linked to various physical and mental conditions.
Pain, Agitation, and Delirium: A Review of Pertinent Guideline Updates for Pharmacists
Treating pain can help decrease agitation, while limiting sedation can help prevent delirium within the ICU.
Applying HIV/AIDS Lessons to the Opioid Crisis
Successful programs feature a mix of social and scientific components.
Guiding Novel Neurologic Drug Approvals
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
Copyright © 2000 - 2026 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.